These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6262255)

  • 1. New category of vasopressin receptor in the central nervous system. Evidence that this receptor mediates the release of a humoral factor VIII-mobilizing principle.
    Cort JH; Fischman AJ; Dodds WJ; Rand JH; Schwartz IL
    Int J Pept Protein Res; 1981 Jan; 17(1):14-22. PubMed ID: 6262255
    [No Abstract]   [Full Text] [Related]  

  • 2. Affinities of reactive vasopressin analogues for bovine antidiuretic receptor.
    Crause P; Fahrenholz F
    Mol Cell Endocrinol; 1982; 28(3):529-41. PubMed ID: 6295844
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced effect of exercise and DDAVP on factor VIII-von Willebrand Factor and plasminogen activator after sequential application of both the stimuli.
    Vicente V; Alberca I; Mannucci PM
    Thromb Haemost; 1984 Feb; 51(1):129-30. PubMed ID: 6426078
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
    Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
    Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel selective hypotensive vasopressin peptides. A new vasodilating vasopressin receptor?
    Chan WY; Wo NC; Stoev S; Cheng LL; Manning M
    Adv Exp Med Biol; 1998; 449():451-3. PubMed ID: 10026838
    [No Abstract]   [Full Text] [Related]  

  • 6. A V1 vasopressin receptor antagonist has nonspecific neurodepressant actions in the spinal cord.
    Porter JP; Brody MJ
    Neuroendocrinology; 1986; 43(1):75-8. PubMed ID: 3012394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1,6-alpha-aminosuberic acid,3-(p-azidophenylalanine), 8-arginine] vasopressin as a photoaffinity label for renal vasopressin receptors: an evaluation.
    Fahrenholz F; Crause P
    Biochem Biophys Res Commun; 1984 Aug; 122(3):974-82. PubMed ID: 6089787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Proline and 4-hydroxyproline analogs of arginine vasopressin: role of the proline substitution in the two beta-turns of vasopressin.
    Buku A; Yamin N; Gazis D
    Experientia; 1987 Dec; 43(11-12):1218-9. PubMed ID: 3691742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroosmotic activities of arginine-vasopressins modified either in positions 1, 2 and 4 or at N-terminal extensions.
    Bakos P; Shakhmatova EI; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
    Gen Physiol Biophys; 1992 Aug; 11(4):359-76. PubMed ID: 1426981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of DDAVP on plasma level of factor XII.
    Nenci GG; Berrettini M; De Cunto M; Agnelli G
    Br J Haematol; 1983 Jul; 54(3):489-92. PubMed ID: 6407513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A minor modification of residue 1 in potent vasopressin antagonists dramatically reduces agonist activity.
    Huffman WF; Albrightson-Winslow C; Brickson B; Bryan HG; Caldwell N; Dytko G; Eggleston DS; Kinter LB; Moore ML; Newlander KA
    J Med Chem; 1989 Apr; 32(4):880-4. PubMed ID: 2522994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological action and binding sites for vasopressin on the mesenteric artery from normal and sodium-depleted rats.
    St-Louis J; Schiffrin EL
    Life Sci; 1984 Oct; 35(14):1489-95. PubMed ID: 6090837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man.
    Cash JD; Gader AM; da Costa J
    Br J Haematol; 1974 Jun; 27(2):363-4. PubMed ID: 4367720
    [No Abstract]   [Full Text] [Related]  

  • 14. Some properties of the human platelet vasopressin receptor.
    Thomas ME; Osmani AH; Scrutton MC
    Thromb Res; 1983 Dec; 32(6):557-66. PubMed ID: 6320489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs.
    Liard JF
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin antagonists: present and future.
    Hofbauer KG; Mah SC
    Kidney Int Suppl; 1987 Aug; 21():S76-82. PubMed ID: 3306108
    [No Abstract]   [Full Text] [Related]  

  • 17. Covalent linkage of [Phe2,Phe(p-N3)3]AVP to vasopressin receptors.
    Eggena P; Fahrenholz F; Schwartz IL
    Am J Physiol; 1984 May; 246(5 Pt 1):C486-93. PubMed ID: 6326607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction of endogenous platelet-activating factor and vasopressin in generating angina in rats.
    Nemcsik J; Kordás K; Egresits J; László F; László FA; Pávó I; Morschl E
    Eur J Pharmacol; 2004 Sep; 498(1-3):195-202. PubMed ID: 15363995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central target for the behavioural effects of vasopressin neuropeptides.
    de Wied D; Gaffori O; van Ree JM; de Jong W
    Nature; 1984 Mar 15-21; 308(5956):276-8. PubMed ID: 6322010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line.
    Aiyar N; Nambi P; Stassen FL; Crooke ST
    Life Sci; 1986 Jul; 39(1):37-45. PubMed ID: 3014249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.